SCHEMBL8720045

SCHEMBL8720045

CCc1c(C)[nH]c(-c2[nH]c(C=O)c(C)c2CCCOC(C)=O)c1CC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
IGF1R P08069 1/20 0.34
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
MAPT P10636 1/20 0.30
STAT1 P42224 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
TSHR P16473 1/20 0.30
BAZ2A Q9UIF9 1/20 0.30
MAPK1 P28482 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6089103 0.77 ALDH1A1 (0.38) ALDH1A1POLBKMT2ACYP2C9CYP2C19
SCHEMBL15380984 0.72 ALDH1A1 (0.36) ALDH1A1POLBKMT2AIGF1RCYP2C9
SCHEMBL5838930 0.66 NPSR1 (0.43) ALDH1A1CYP2C9CYP2C19CYP1A2RAB9A
SCHEMBL8840819 0.66 MAPK1 (0.47) ALDH1A1POLBKMT2ACYP2C9CYP1A2
SCHEMBL15331650 0.65 MAPK1 (0.52) ALDH1A1POLBKMT2ACYP2C9CYP2C19
SCHEMBL6273007 0.65 ALDH1A1 (0.45) ALDH1A1POLBKMT2ACYP2C9CYP2C19
SCHEMBL4199341 0.65 ALDH1A1 (0.65) ALDH1A1POLBKMT2AIGF1RCYP2C9
SCHEMBL8686614 0.63 KDM4E (0.38) ALDH1A1POLBCYP2C9CYP2C19CYP1A2
SCHEMBL29954782 0.63 ALDH1A1 (0.37) ALDH1A1POLBKMT2AIGF1RCYP2C9
SCHEMBL6740330 0.63 FGFR1 (0.44) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5733903-A ANTITUMOR AGENTS WITH DIAMAGNETISM BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-03-31 US disclosed